These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 14108831)

  • 1. [COMBINED THERAPY WITH RIFOMYCIN AND CHYMOTRYPSIN IN SURGICAL PATIENTS].
    VERNONI S
    Riv Patol Clin; 1963 Sep; 18():443-50. PubMed ID: 14108831
    [No Abstract]   [Full Text] [Related]  

  • 2. [New prospects for systemic enzyme therapy in obstetrics and gynecology].
    LURASCHI C
    Minerva Ginecol; 1963 Mar; 15():313-6. PubMed ID: 13931764
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapeutic trials of a trypsin-alpha-chymotrypsin combination in edema of venous origin and hydrolipopexia].
    LINQUETTE M
    Lille Med; 1963; 8():569-73. PubMed ID: 13930864
    [No Abstract]   [Full Text] [Related]  

  • 4. [The prevention of suppurative complications after surgical operations].
    Grigorian AV; Lokhvitskiĭ SV
    Khirurgiia (Mosk); 1969 May; 45(5):7-13. PubMed ID: 5347814
    [No Abstract]   [Full Text] [Related]  

  • 5. [RIFAMYCIN SV IN THE TREATMENT OF SOME POSTOPERATIVE COMPLICATIONS OF ECHINOCOCCAL CYSTS OF LIVER].
    DOGLIOTTI G
    Gazz Int Med Chir; 1964 Feb; 68():403-11. PubMed ID: 14136665
    [No Abstract]   [Full Text] [Related]  

  • 6. [CLINICAL STUDY OF THE THERAPEUTIC ACTION OF RIFAMYCIN SV IN THE LOCAL TREATMENT OF POST-OPERATIVE CUTANEOUS FISTULA].
    SACINO G
    Gazz Int Med Chir; 1963 Sep; 67():1894-911. PubMed ID: 14088389
    [No Abstract]   [Full Text] [Related]  

  • 7. [Intramuscular administration of combined trypsin and chymotrypsin in therapy of thrombophlebitis of obstetric and gynecological origin].
    LURASCHI C
    Riv Ostet Ginecol Prat; 1957 Dec; 39(12):1163-91. PubMed ID: 13528759
    [No Abstract]   [Full Text] [Related]  

  • 8. [Prevention of edema and postoperative hematoma in plastic surgery of the face].
    VIDAL L
    Prog Med (Paris); 1963 Jun; 91():425-6. PubMed ID: 13997085
    [No Abstract]   [Full Text] [Related]  

  • 9. [ON THE USE OF RIFAMYCIN IN SURGERY].
    FERRANTE G
    Chemotherapia (Basel); 1963; 27():331-43. PubMed ID: 14128795
    [No Abstract]   [Full Text] [Related]  

  • 10. [Enzyme therapy as a physiologically based method of treating acute suppurative diseases of the soft tissues].
    Gostishchev VK; Dzhalilov NG
    Vestn Khir Im I I Grek; 1969 Aug; 103(8):73-6. PubMed ID: 5407846
    [No Abstract]   [Full Text] [Related]  

  • 11. [RIFAMYCIN SV IN THE SUPPURATING AFFECTIONS OF THE LOCOMOTOR APPARATUS].
    BRENNER EA; GIANI O
    Sem Med; 1963 Jun; 122():1468-72. PubMed ID: 14069264
    [No Abstract]   [Full Text] [Related]  

  • 12. [USE OF A COMBINATION OF ORAL ALPHA-CHYMOTRYPSIN AND TRYPSIN IN GENERAL SURGERY].
    GALAVERNA J; MONSAINGEON A
    Rev Int Serv Sante Armees; 1964; 37():603-8. PubMed ID: 14212635
    [No Abstract]   [Full Text] [Related]  

  • 13. [ASSOCIATION OF TRYPSIN-ALPHA-CHYMOTRYPSIN BY ORAL ROUTE IN GENERAL SURGERY AND TRAUMATOLOGY].
    CORNET J
    Lyon Med; 1964 Sep; 212():447-57. PubMed ID: 14207159
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of trypsin & chymotrypsin in the management of post-operative oedema.
    Gupta MK; Khanna JN; Khera SS
    J Indian Dent Assoc; 1985 Mar; 57(3):101-5. PubMed ID: 3865958
    [No Abstract]   [Full Text] [Related]  

  • 15. [PROTEOLYTIC ENZYMES IN THE COMBINED TREATMENT OF PATIENTS WITH TUBERCULOSIS AND SUPPURATIVE DISEASES OF THE LUNG AND PLEURA].
    PILIPCHUK NS; VEREMEENKO KN
    Klin Med (Mosk); 1963 Dec; 41():42-51. PubMed ID: 14148117
    [No Abstract]   [Full Text] [Related]  

  • 16. [STUDY OF A TRYPSIN-ALPHA-CHYMOTRYPSIN COMBINATION ACTIVE BY BUCCAL ROUTE IN PROCTOLOGY AND PROCTOLOGICAL SURGERY].
    DOREAU JL
    Gaz Med Fr; 1964 Apr; 71():1426-9. PubMed ID: 14143814
    [No Abstract]   [Full Text] [Related]  

  • 17. [Use of liposomes and biologically active soluble antibiotics in the prevention and treatment of postoperative infectious-suppurative complications].
    Gilenko IO; Shevchenko VS; Dikiĭ IL; Strel'nikov LS; Bashtan VP
    Klin Khir; 1996; (10):53-4. PubMed ID: 9162569
    [No Abstract]   [Full Text] [Related]  

  • 18. [ON THE IMPORTANCE OF A NEW DRUG COMBINATION CONTAINING PANCREATIC ENZYMES AND TETRACYCLINE IN O.R.L].
    CAJGFINGER H; LAPICOREY G
    Lyon Med; 1964 Oct; 212():877-82. PubMed ID: 14214545
    [No Abstract]   [Full Text] [Related]  

  • 19. [USE AND ACTION OF THE NEW ANTIBIOTIC RIFAMYCIN SV (RIFOCIN)].
    ANSCHEL R
    Wien Med Wochenschr; 1965 Mar; 115():197-202. PubMed ID: 14260791
    [No Abstract]   [Full Text] [Related]  

  • 20. [RIFAMYCIN SV ASSOCIATED WITH HYDROSOLUBLE CONTRAST MEDIUM IN THE PREVENTION OF RISK OF INFLAMMATION IN HYSTEROSALPINGOGRAPHY (H.S.G.) AND GYNECOHYSTEROSALPINGOGRAPHY (G.H.S.)].
    GIANNICE C
    Chemotherapia (Basel); 1963; 10():617-20. PubMed ID: 14184799
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.